Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4
|
作者：
Cai, Jiayu [1 ,2 ]
Xu, Weizhi [1 ,2 ]
Meng, Tinghua [1 ,2 ]
Pang, YiZhen [1 ,2 ]
Chen, Haojun [1 ,2 ,3 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China
[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期
基金：
中国国家自然科学基金;
关键词：
F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;
D O I：
10.1097/RLU.0000000000004719
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 50 条
  • [1] 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer
    Tatar, Gamze
    Ergul, Nurhan
    Baloglu, Mehmet Can
    Arslan, Esra
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E135 - E137
  • [2] Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT
    Parida, Girish Kumar
    Tripathy, Sarthak
    Gupta, Shreya Datta
    Singhal, Abhinav
    Kumar, Rakesh
    Bal, Chandrasekhar
    Shamim, Shamim Ahmed
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 248 - 249
  • [3] 68Ga-FAPI and 18F-FDG PET/CT in Intravenous Leiomyomatosis
    Li, Zhuoyuan
    Su, Dan
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 994 - 996
  • [4] Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
    Cheng, Zhaoting
    Zou, Sijuan
    Cheng, Siyuan
    Song, Shuang
    Zhu, Xiaohua
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : 764 - 765
  • [5] 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma
    Chen, Ew-Jun
    Tan, Teik Hin
    Chew, Ming Tsuey
    Chye, Ping Ching
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : E317 - E319
  • [6] 18F-FDG and 68Ga-PSMA PET/CT in Paratesticular Mesothelioma
    Kalantari, Forough
    Schweighofer-Zwink, Gregor
    Rendl, Gundula
    Pirich, Christian
    Beheshti, Mohsen
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (04) : 332 - 332
  • [7] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans
    Wu, Junhao
    Zhang, Shumao
    Rao, Zijuan
    Wang, Yingwei
    Zhang, Chunyin
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : 629 - 631
  • [8] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Finger Hidradenocarcinoma
    Wang, Jie
    Wu, Junhao
    Guan, Yihui
    Xu, Jing
    Xie, Fang
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E124 - E125
  • [9] Comparison of 68Ga-FAPI and 18F-PSMA PET/CT in the Evaluation of Ductal Adenocarcinoma of the Prostate
    Liu, C.
    Xie, Q.
    Liu, T.
    Li, Z.
    Guo, C.
    Yang, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S522 - S522
  • [10] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in metastasis of thyroid papillary carcinoma
    Ou, Lei
    Wu, Ji
    Yang, Fanhui
    Zhang, Chunyin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (01): : 100 - 101
12345